The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice

被引:67
作者
Cui, F
Wang, YL
Wang, J
Wei, KK
Hu, JQ
Liu, F
Wang, HL
Zhao, XH
Zhang, XM
Yang, X
机构
[1] Inst Biotechnol, Genet Lab Dev & Dis, Beijing 100071, Peoples R China
[2] Natl Ctr Biomed Anal, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100037, Peoples R China
[4] Peking Union Med Coll, Beijing, Peoples R China
关键词
transgenic; hepatocelluar carcinoma; HBx; proteasome;
D O I
10.1002/pmic.200500218
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Chronic infection of hepatitis virus B (HBV) has been proven to be one of the most important risk factors of hepatocellular carcinoma (HCC). HBx has been shown to function in the viral life cycle and the development of HCC. Recently, we have reported that HBx transgenic mice (p21-HBx), generated by gene knockin, develop HCC at the age of 18 months. To further study the function of HBx during the development of HCC in vivo, we performed proteomic analysis of the transgenic and wild-type control mice. The combination of 2-DE and MALDI-TOF MS revealed that proteasome subunits (PSMA6, PSMB4, PSMC2 and PSMD12) were up-regulated in tumor tissues of the p21-HBx transgenic mice. Cathepsin B, ubiquinol-cytochrome C reductase core protein 1 and an ATP-dependent caseinolytic protease, which were involved in the cellular proteolytic process, were also found increased in tumors. The results were confirmed in tumors of transgenic mice and HCCs of human using RT-PCR. All these results suggested that the strengthened ubiquitin-proteasome and lysosomal pathway might contribute to the development of HBx-related H CC.
引用
收藏
页码:498 / 504
页数:7
相关论文
共 37 条
[1]   The development of proteasome inhibitors as anticancer drugs [J].
Adams, J .
CANCER CELL, 2004, 5 (05) :417-421
[2]  
ARII M, 1992, ONCOGENE, V7, P397
[3]  
ARRIBAS J, 1993, J BIOL CHEM, V268, P21165
[4]  
Choi YH, 2001, INT J ONCOL, V19, P687
[5]   Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[6]   The proteasome, a novel protease regulated by multiple mechanisms [J].
DeMartino, GN ;
Slaughter, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22123-22126
[7]   Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials [J].
Ding, SJ ;
Li, Y ;
Shao, XX ;
Zhou, H ;
Zeng, R ;
Tang, ZY ;
Xia, QC .
PROTEOMICS, 2004, 4 (04) :982-994
[8]   The complete primary structure of mouse 20S proteasomes [J].
Elenich, LA ;
Nandi, D ;
Kent, AE ;
McCluskey, TS ;
Cruz, M ;
Iyer, MN ;
Woodward, EC ;
Conn, CW ;
Ochoa, AL ;
Ginsburg, DB ;
Monaco, JJ .
IMMUNOGENETICS, 1999, 49 (10) :835-842
[9]   Ubiquitin-dependent protein degradation [J].
Hochstrasser, M .
ANNUAL REVIEW OF GENETICS, 1996, 30 :405-439
[10]   Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex [J].
Hu, ZY ;
Zhang, ZS ;
Doo, E ;
Coux, O ;
Goldberg, AL ;
Liang, TJ .
JOURNAL OF VIROLOGY, 1999, 73 (09) :7231-7240